Influenza epidemiology and vaccine effectiveness among patients with influenza-like illness, viral watch sentinel sites, South Africa, 2005-2009

PLoS ONE

Volumn 9, Issue 4, 2014, Pages

  Ntshoe, Genevie M ^a   McAnerney, Johanna M ^a   Tempia, Stefano ^a   Blumberg, Lucille ^a   Moyes, Jocelyn ^a   Buys, Amelia ^a   Naidoo, Dhamari ^b   Venter, Marietjie ^a   Besselaar, Terry ^b   Schoub, Barry D ^a   Harris, Bernice N ^c   Cohen, Cheryl ^a  

^a NATIONAL INSTITUTE FOR COMMUNICABLE DISEASES   (South Africa)

^b WORLD HEALTH ORGANIZATION   (Switzerland)

^c UNIVERSITY OF PRETORIA   (South Africa)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE;

ADOLESCENT; ADULT; AGE DISTRIBUTION; AGED; CHILD; CONTROLLED STUDY; DRUG EFFICACY; HEMAGGLUTINATION INHIBITION TEST; HUMAN; INFLUENZA; INFLUENZA A; INFLUENZA A (H1N1); INFLUENZA A(H1N1) PDM09 VIRUS; INFLUENZA B; INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; MAJOR CLINICAL STUDY; NONHUMAN; NOSE SMEAR; PANDEMIC INFLUENZA; POLYMERASE CHAIN REACTION; PROGRAM EFFECTIVENESS; REAL TIME POLYMERASE CHAIN REACTION; REVIEW; SEASONAL INFLUENZA; SEASONAL VARIATION; SENTINEL SURVEILLANCE; SOUTH AFRICA; THROAT CULTURE; VIRUS DETECTION; EPIDEMIOLOGY; IMMUNOLOGY; INFANT; INFLUENZA, HUMAN; ISOLATION AND PURIFICATION; MIDDLE AGED; NEWBORN; PANDEMICS; PHYSIOLOGY; PRESCHOOL CHILD; SEASON; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHILD; CHILD, PRESCHOOL; HUMANS; INFANT; INFANT, NEWBORN; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PANDEMICS; SEASONS; SENTINEL SURVEILLANCE; SOUTH AFRICA; YOUNG ADULT;

EID: 84899693218     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0094681     Document Type: Review

References (38)

1. Heyman DL, editor (2004) Control of Communicable Diseases Manual. 18th ed. Washington: American Public Health Association: 281-287.
2. Radin JM, Katz MA, Tempia S, Nzussouo NT, Davis R, et al. (2012) Influenza Surveillance in 15 Countries in Africa, 2006-2010. JID 206 (Suppl 1): S14-21.
3. World Health Organisation. Influenza Facts sheet No 211, Revised March 2003. Available: http://www.who.int/mediacentre/factsheets/2003/fs211/en. Accessed 2011 Dec 19.
4. Statistics South Africa. Mortality and causes of death in South Africa, 2005: Findings from death notification. Available: http://www.statssa.gov.za/ publications/P03093/P030932005.pdf. Accessed 2011 Dec 19.
5. Statistics South Africa. Mortality and causes of death in South Africa, 2006: Findings from death notification. Available: http://www.statssa.gov.za/ publications/P03093/P030932006.pdf. Accessed 2011 Dec 19.
6. Statistics South Africa. Mortality and causes of death in South Africa, 2007: Findings from death notification. Available: http://www.statssa.gov.za/ publications/P03093/P030932007.pdf. Accessed 2011 Dec 19.
7. Statistics South Africa. Mortality and causes of death in South Africa, 2008: Findings from death notification. Available: http://www.statssa.gov.za/ publications/P03093/P030932008.pdf. Accessed 2011 Dec 19.
8. Statistics South Africa. Mortality and causes of death in South Africa, 2009: Findings from death notification. Available: http://www.statssa.gov.za/ publications/P03093/P030932009.pdf. Accessed 2011 Dec 19.
9. World Health Organisation. WHO Global Influenza Surveillance Network. Available: http://www.who.int/influenza/gisrs-laboratory/en/. Accessed 2011 Jun 30.
10. World Health Organisation (2009) Human infection with pandemic A (H1N1) 2009 influenza virus: clinical observations in hospitalized patients, Americas, July 2009- update. Wkly Epidemiol Rec 84: 305-308.
11. Archer BN, Cohen C, Naidoo D, Thomas J, Makunga C, et al. (2009) Interim report on pandemic H1N1 influenza virus infections in South Africa, April to October 2009: Epidemiology and factors associated with fatal cases. Euro Surveill 14(42): pii = 19369. Available: http://www.eurosurveillance.org/ Viewarticle.aspx?ArticleId= 19369.
12. WHO Report on Global surveillance of Epidemic-prone Infectious Diseases. Available: http://whglibdoc.who.int/hq/2000/WHO-CDS-CSR-ISR-2000. 1.pdf. Accessed 2011 Mar 23.
13. Schoub, BD. Recommendations pertaining to the use of viral vaccines: Influenza 2009. SAMJ 99(2): 87.
14. World Health Organisation (2011) Targeting influenza in Africa: strategic actions for assessing the impact of the disease and for developing control measures. Wkly Epidemiol Rec 86(23): 223-240.
15. Katz MA, Schoub BD, Heraud M, Breiman RF, Njenga MK, et al. (2012) Influenza in Africa: Uncovering the Epidemiology of a Long-Overlooked Disease. JID 206 (Suppl 1): S1-4.
16. Skowronski DM, Masaro C, Kwindt, Mak A, Petric M, et al. (2007) Estimating vaccine effectiveness against laboratory-confirmed influenza using a sentinel physician network: Results from the 2005-2006 season of dual A and B vaccine mismatch in Canada. Vaccine 25: 2842-2851. (Pubitemid 46412567)
17. Kelly H, Carville K, Grant K, Jacoby P, Tran T, et al. (2009) Estimation of Influenza Vaccine effectiveness from Routine Surveillance Data. PLos ONE 4(3): e5079.doi:10.1371/journal.pone.0005079.
18. McAnerney JM, Cohen C, Moyes J, Besselaar T, Buys A, et al. (2012) Twentyfive Years of Outpatient Influenza Surveillance in South Africa, 1984-2008. JID 206 (Suppl 1): S153-158.
19. World Health Organisation (2010) Bridging the gap in South Africa. Bull World Health Organ 88: 803-804.
20. Jackson ML, Nelson JC (2013). The test-negative design for estimating influenza vaccine effectiveness. Vaccine 31: 2165-2168.
21. De Serres G, Skowronski DM, Wu XW, Ambrose CS (2013). The test-negative design: validity, accuracy and precision of vaccine efficacy estimates compared to the gold standard of randomised placebo-controlled clinical trials. Euro Surveill 18(37): pii =20585.
22. Skowronski DM, De Serres G, Dickson J, Petric M, Mak A, et al. (2009) Component-Specific Effectiveness of Trivalent Influenza Vaccine as Monitored through a sentinel Surveillance Network in Canada, 2006-2007. JID 199: 168-179.
23. McAnerney J, Besselaar T, Buys A, Esterhuyse C, Cohen C, et al. (2007) Respiratory Virus Surveillance, South Africa, 2006. Communicable Diseases Surveillance Bulletin 5(1): 5. Available: http://www.nicd.ac.za/pubs/survbull/ 2007/CommDisBullMarch07.pdf. Accessed 2011 Sep 19.
24. McAnerney J, Besselaar T, Buys A, Esterhuyse C, Naidoo D, et al. (2008) Respiratory Virus Surveillance, South Africa, 2007. Communicable Diseases Surveillance Bulletin 6(1): 7. Available: http://www.nicd.ac.za/pubs/survbull/ 2008/CommDisBullMarch08.pdf. Accessed 2011 Sep 19.
25. Tricco AC, Chit A, Soobiah C, Hallett D, Meier G, et al. (2013) Comparing influenza vaccine efficacy against mismatched and matched strains: a systematic review and meta-analysis. BMC Medicine 11: 153.
26. Kelly H, Grant K (2009) Interim analysis of pandemic influenza (H1N1) 2009 in Australia: surveillance trends, age of infection and effectiveness of seasonal vaccination. Euro Surveill 14(31): pii-19288. Available: http://www. eurosurveillance.org/ViewArticle.aspx?ArticleId = 19288.
27. Hancock K, Veguilla V, Lu X, Zhong W, Butler EN, et al. (2009) Cross- Reactive Antibody Responses to the 2009 Pandemic H1N1 Influenza Virus. N Eng J Med 361(20): 1945-1952.
28. Centers for Disease Control and Prevention (2010). Serum Cross-Reactive Antibody Response to a novel Influenza A (H1N1) Virus After Vaccination with Seasonal Influenza Vaccine. MMWR Morb Mortal Wkly Rep 58 (19): 521-524.
29. Cowling BJ, Ng S, Ma ESK, Cheng CKY, Wai W, et al. (2010) Protective Efficacy of Seasonal Influenza Vaccination against Seasonal and Pandemic Influenza Virus Infection during 2009 in Hong Kong. CID 51(12): 1370-1379.
30. World Health Organisation (2002) Influenza vaccines. Wkly Epidemiol Rec 77 (28): 230-239.
31. World Health Organisation. Report of the 1st Africa Flu Alliance meeting 3-4 June 2010 Marrakesh, Morocco. WHO/HSE/GIP/DAC/2011.1.
32. Shiley KT, Nadolski G, Mickus T, Fishman NO, Lautenbach E (2010) Differences in the epidemiologic characteristics and clinical outcomes of pandemic compared with seasonal. Infect Control Hosp Epidemiol 31(7): 676-682. doi:10.1086/653204.
33. Carcione D, Giele C, Dowse GK, Mak DB, Goggin L, et al. (2010) Comparison of pandemic (H1N1) 2009 and seasonal influenza, Western Australia, 2009. Emerg Infect Dis DOI: 10.3201/eid1609.100076.
34. Theocharis G, Vouloumanou EK, Barbas SG, Spiropoulos T, Rafailidis PI, et al. (2011) Comparison of characteristics of outpatients with 2009 H1N1 pandemic and seasonal influenza. Int J Clin Pract 65(8): 871-878.
35. Dolin R, Wise TG, Mazur MH, Tuazon CU, Ennis FA (1977) Immunogenicity and reactogenicity of influenza A/new Jersey/76 virus vaccines in normal adults. JID 136 Suppl: S435-442. (Pubitemid 8293885)
36. Cate TR, Kasel JA, Couch RB, Six HR, Knight V (1977) Clinical trials of bivalent influenza A/new Jersey/76-A/Victoria/75 vaccines in the elderly. JID 136 Suppl: S518-525. (Pubitemid 8293898)
37. Van Kerkhove MD, Mounts AW, Mall S, Vandemaele KAH, Chamberland M, et al. (2011) Epidemiologic and virologic assessment of the 2009 influenza A (H1N1) pandemic on selected temperate countries in the Southern Hemisphere: Argentina, Australia, Chile, New Zealand and South Africa. Influenza and Other Resp Viruses 5(6): e487-98 DOI:10.1111/j.1750-2659.2011.00249.x.
38. Kissling E, Valenciano M, I-MOVE case-control studies team (2011) Early estimates of seasonal influenza effectiveness in Europe, 2010/2011: I-MOVE, a multicenter case-control study. Euro Surveill 16(11): pii = 19818.